B-Bridge International said that it has released its siSolutions line of RNAi products, including custom siRNAs, in Japan.
The company said the products would be made available in North America in the beginning of December.
Ambion has recently introduced the siPort NeoFx transfection agent.
The company said the product’s lipid-based formulation can be used to efficiently transfect adherent cells with siRNAs as they are subcultured without increased cytotoxicity.